MedTrace Logo

Assessment of Patients With Hepatitis C Virus Related Liver Cirrhosis After Sustained Response to Direct Acting Anti Viral Drugs.

NCT03241823 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2017-08-08

No results posted yet for this study

Summary

Hepatitis C Virus (HCV) infection is a major global health challenge; it is estimated that more than 80 million people are chronically infected worldwide, with 3-4 million new infections and 350,000 deaths occurring each year because of HCV-related complications .

Conditions

Interventions

DIAGNOSTIC_TEST

Abdominal ultrasound .

Abdominal ultrasound for each patient before and after treatment.

DIAGNOSTIC_TEST

Model for End-Stage Liver Disease

Model for End-Stage Liver Disease before and after treatment.

DIAGNOSTIC_TEST

Fibro Scan.

Liver stiffness by Fibro scan before and after treatment.

DIAGNOSTIC_TEST

Child-Turcotte-Pugh score.

Child-Turcotte-Pugh score before and after treatment

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Ibrahim Taha, MSc · Assiut University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-01
Primary Completion
2019-01-31
Completion
2019-03-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03241823 on ClinicalTrials.gov